Is Pheochromocytoma hereditary?

TL;DR: While most cases of pheochromocytoma occur sporadically, approximately 30% to 40% are hereditary, caused by an underlying germline genetic mutation. Patients diagnosed with pheochromocytoma should consult with a clinical geneticist to determine if their condition is part of a broader genetic syndrome, as this significantly impacts long-term monitoring and family planning.

Is pheochromocytoma considered a hereditary condition?

Pheochromocytoma is often both genetic and hereditary, though it is important to distinguish between these terms. A "genetic" condition is caused by changes in DNA, while a "hereditary" condition is passed from parent to child. In about 30% to 40% of individuals, a pheochromocytoma is the result of a germline mutation—a mutation present in every cell of the body—which can be inherited from a parent or occur as a de novo (spontaneous) event. The remaining cases are considered sporadic, meaning they occur due to somatic mutations that are not passed to offspring.

What are the inheritance patterns of pheochromocytoma?

When pheochromocytoma is hereditary, it typically follows an autosomal dominant inheritance pattern. This means that an individual only needs to inherit one copy of the mutated gene from one parent to be at risk for developing the tumor. Because these syndromes are autosomal dominant, children of an affected parent have a 50% chance of inheriting the specific genetic mutation. It is important to note that even if a person inherits the mutation, they may not develop the tumor at the same age or with the same severity as other family members, a concept known as variable expressivity and incomplete penetrance.

Which genetic syndromes are associated with pheochromocytoma?

Pheochromocytoma is rarely an isolated finding when it has a genetic cause; it is frequently a clinical feature of several well-defined hereditary syndromes. Recognizing these associations is vital for clinical management:

• Von Hippel-Lindau (VHL) syndrome: Caused by mutations in the VHL gene.


• Multiple Endocrine Neoplasia type 2 (MEN2): Associated with RET proto-oncogene mutations.


• Neurofibromatosis type 1 (NF1): Caused by mutations in the NF1 gene.


• Hereditary Paraganglioma-Pheochromocytoma Syndromes: Often linked to mutations in succinate dehydrogenase genes (e.g., SDHA, SDHB, SDHC, SDHD).

When is genetic testing recommended?

Given the high prevalence of germline mutations, current clinical guidelines recommend that all patients diagnosed with pheochromocytoma undergo genetic counseling and testing. Genetic testing is particularly crucial for younger patients, those with bilateral tumors, or those with a personal or family history of related endocrine tumors. Genetic counseling provides a space for families to discuss the implications of test results, the potential for de novo mutations in cases with no family history, and the necessity of screening for at-risk relatives.

How does this impact family planning and prenatal options?

For families with a known hereditary mutation, genetic counseling is essential before and during pregnancy. Preimplantation genetic testing (PGT) may be available for couples who wish to avoid passing the mutation to their children. Because pheochromocytoma can cause significant cardiovascular complications during pregnancy, early diagnosis and genetic risk assessment are vital for the safety of both the parent and the fetus. At DiseaseMaps.org, we have seen 165 community members with pheochromocytoma share their experiences, many of whom emphasize the importance of early genetic screening for their relatives.

Next steps

• Schedule an appointment with a clinical geneticist or a genetic counselor to discuss your specific diagnosis.


• Request a referral to an endocrine oncologist to discuss long-term surveillance protocols.


• Share your diagnosis with immediate family members so they can seek appropriate genetic screening.


• Join the DiseaseMaps.org community to connect with others navigating the complexities of pheochromocytoma.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding your specific health condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Pheochromocytoma.


• Orphanet: Hereditary pheochromocytoma-paraganglioma syndromes.


• OMIM (Online Mendelian Inheritance in Man): Database of genetic associations for endocrine tumors.


• Endocrine Society: Clinical Practice Guidelines for Pheochromocytoma and Paraganglioma.